Xenon Pharmaceuticals Inc.

By person

11 insiders · 29 transactions

1.5×

Ian Mortimer holds only 1.5 times base salary in stock. $1.21M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MORTIMER IAN

PRESIDENT & CEO

—

$21.30M (18) scheduled

−$21.30M

19,923

0.0206%

$1.21M

−36.4%

KENNEY CHRISTOPHER JOHN

Chief Medical Officer

—

$670.26K (4) scheduled

−$670.26K

<0.0001%

$121.95

+100.0%

GANNON STEVEN

Director

—

$640.55K (1)

−$640.55K

1,870

0.0019%

$114.03K

−6.5%

DiFabio Andrea

Chief Legal Officer

—

$230.81K (2) scheduled

−$230.81K

7,301

0.0075%

$445.19K

—

PATOU GARY

Director

—

$70.25K (1) scheduled

−$70.25K

24,896

0.0257%

$1.52M

+5.6%

Cannon Gillian

Director

—

$63.24K (1) scheduled

−$63.24K

1,455

0.0015%

$88.72K

—

Svoronos Dawn

Director

—

31,373

0.0324%

$1.91M

+25.5%

Machado Patrick

Director

—

2,645

0.0027%

$161.28K

—

Gover Justin D.

Director

—

2,645

0.0027%

$161.28K

—

GAROFALO ELIZABETH A.

Director

—

2,645

0.0027%

$161.28K

—

AULIN SHERRY

Chief Financial Officer

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Svoronos Dawn

1 Sep 2026

Director

Exercised, kept

5,144

$8.15

$41.92K

KENNEY CHRISTOPHER JOHN

28 Aug 2026

Chief Medical Officer

Sold on a plan

700

$60.98

$42.68K

KENNEY CHRISTOPHER JOHN

28 Aug 2026

Chief Medical Officer

Sold on a plan

6,368

$60.17

$383.15K

GANNON STEVEN

11 Aug 2026

Director

Sell

10,000

$64.06

$640.55K

Cannon Gillian

5 Jun 2026

Director

Sold on a plan

1,190

$53.14

$63.24K

PATOU GARY

5 Jun 2026

Director

Sold on a plan

1,322

$53.14

$70.25K

GANNON STEVEN

12 May 2026

Director

Exercised, kept

3,500

$7.38

$25.83K

MORTIMER IAN

13 Mar 2026

PRESIDENT & CEO

Sold on a plan

7,308

$55.23

$403.58K

DiFabio Andrea

13 Mar 2026

Chief Legal Officer

Sold on a plan

1,342

$55.23

$74.11K

KENNEY CHRISTOPHER JOHN

13 Mar 2026

Chief Medical Officer

Sold on a plan

1,410

$55.23

$77.87K

MORTIMER IAN

10 Mar 2026

PRESIDENT & CEO

Sold on a plan

11,269

$60.11

$677.36K

DiFabio Andrea

10 Mar 2026

Chief Legal Officer

Sold on a plan

2,607

$60.11

$156.70K

KENNEY CHRISTOPHER JOHN

10 Mar 2026

Chief Medical Officer

Sold on a plan

2,771

$60.11

$166.56K

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

65,000

$62.06

$4.03M

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

61,652

$60.08

$3.70M

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

43,348

$59.26

$2.57M

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

2,449

$61.26

$150.03K

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

10,072

$60.47

$609.05K

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

12,479

$59.50

$742.50K

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

21,515

$60.49

$1.30M

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

31,694

$59.88

$1.90M

MORTIMER IAN

9 Mar 2026

PRESIDENT & CEO

Sold after exercise

21,791

$58.81

$1.28M

MORTIMER IAN

2 Jan 2026

PRESIDENT & CEO

Sold after exercise

2,062

$44.93

$92.65K

MORTIMER IAN

2 Jan 2026

PRESIDENT & CEO

Sold after exercise

37,938

$44.40

$1.68M

MORTIMER IAN

8 Dec 2025

PRESIDENT & CEO

Sold on a plan

2,010

$46.32

$93.10K

MORTIMER IAN

8 Dec 2025

PRESIDENT & CEO

Sold on a plan

8,820

$45.59

$402.10K

MORTIMER IAN

5 Dec 2025

PRESIDENT & CEO

Sold on a plan

14,375

$45.03

$647.31K

MORTIMER IAN

28 Nov 2025

PRESIDENT & CEO

Sold on a plan

$45.01

$4.37K

MORTIMER IAN

1 Oct 2025

PRESIDENT, CEO & INTERIM CFO

Sold after exercise

25,000

$40.16

$1.00M

Xenon Pharmaceuticals Inc.

By person

Individual transactions

What was left out